Patent · US Active

Antibodies to ICOS

US10023635B2 · kind B2 · utility

2Cited by

20References

47Claims

0Family size

Assignee

Jounce Therapeutics, Inc. · US

Inventors

Stephen Sazinsky · Melrose, US
Jennifer Michaelson · Cambridge, US
Sriram Sathyanarayanan · Lexington, US
Kutlu Goksu Elpek · Arlington, US

Key dates

Filing date	Mar 22, 2016
Grant date	Jul 17, 2018
Priority date	—
Expiry date	Nov 7, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are various embodiments relating to antibodies. Some of the embodiments include agonist antibodies that bind ICOS. Such antibodies can be used in methods to treat, for example, cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.